Expression of CPEB, GAPDH and U6snRNA in cervical and ovarian tissue during cancer development

Persistent infection with high‐risk human papillomavirus (HPV) and expression of the proteins E6 and E7 is a prerequisite for development of cervical cancer. The distal non‐coding part of E6/E7 messengers from several HPV types is able to downregulate synthesis of a reporter gene through mechanisms with involvement of cytoplasmic polyadenylation elements (CPEs) in the messengers. We here show that the mRNA levels of one of the four known CPE‐binding proteins (CPEBs), the CPEB3, were downregulated in HPV‐positive cervical cancers, whereas in ovarian cancer the CPEB1 mRNA level was downregulated. In addition, we showed that the RNA levels of the widely used reference marker GAPDH were upregulated in both cancer forms, and the level of the reference marker U6snRNA was upregulated in cervical cancers. Moreover, a possible correlation between the degree of U6snRNA upregulation and cervical cancer propagation was shown. These changes observed in CPEB1 and CPEB3 might indicate regulatory functions of CPEBs in cancer development of HPV‐positive and HPV‐negative tumors, respectively, and the U6snRNA, GAPDH mRNA and CPEB1 mRNA levels may be useful as tumor markers for genital cancers although further investigations are needed.

[1]  V. Moreno,et al.  Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. , 1995, Journal of the National Cancer Institute.

[2]  B. Norrild,et al.  The 3' region of Human Papillomavirus type 16 early mRNAs decrease expression , 2005, BMC infectious diseases.

[3]  N. Muñoz,et al.  Human papillomavirus and cancer: the epidemiological evidence. , 2000, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[4]  Julian Peto,et al.  Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective , 1995 .

[5]  J. Doorbar,et al.  Molecular biology of human papillomavirus infection and cervical cancer. , 2006, Clinical science.

[6]  Eric R. Kandel,et al.  Two previously undescribed members of the mouse CPEB family of genes and their inducible expression in the principal cell layers of the hippocampus , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[7]  H. Hausen,et al.  Molecular cloning and characterization of the dna of a new human papillomavirus (hpv 30) from a laryngeal carcinoma , 1986, International journal of cancer.

[8]  J. Richter,et al.  CPEB controls oocyte growth and follicle development in the mouse , 2006, Development.

[9]  Claude Fauquet,et al.  Classification of papillomaviruses. , 2004, Virology.

[10]  N. Muñoz,et al.  Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. , 2007, The Lancet. Infectious diseases.

[11]  M. Azodi,et al.  Glyceraldehyde-3-phosphate dehydrogenase binds to the AU-Rich 3' untranslated region of colony-stimulating factor-1 (CSF-1) messenger RNA in human ovarian cancer cells: possible role in CSF-1 posttranscriptional regulation and tumor phenotype. , 2005, Cancer research.

[12]  U. Liebert,et al.  PCR detection of human papillomavirus of the mucosa: comparison between MY09/11 and GP5+/6+ primer sets. , 2004, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[13]  Xavier Castellsagué,et al.  Chapter 1: HPV in the etiology of human cancer. , 2006, Vaccine.

[14]  J. Ferlay,et al.  Worldwide burden of gynaecological cancer: the size of the problem. , 2006, Best practice & research. Clinical obstetrics & gynaecology.

[15]  A. Ganser,et al.  Lentivirus-mediated antagomir expression for specific inhibition of miRNA function , 2007, Nucleic acids research.

[16]  R. Méndez,et al.  Translational control by CPEB: a means to the end , 2001, Nature Reviews Molecular Cell Biology.

[17]  K. Fujimori,et al.  Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. , 1987, Cancer research.

[18]  Yi-shuian Huang,et al.  CPEB3 and CPEB4 in neurons: analysis of RNA‐binding specificity and translational control of AMPA receptor GluR2 mRNA , 2006, The EMBO journal.

[19]  S. Gaines,et al.  The Mouse , 2011 .

[20]  Roger J. Davis,et al.  Control of cellular senescence by CPEB. , 2006, Genes & development.

[21]  P. Arcari,et al.  The complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: evidence for multiple mRNA species. , 1984, Nucleic acids research.

[22]  Eileen M. Burd,et al.  Human Papillomavirus and Cervical Cancer , 1988, The Lancet.

[23]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[24]  D. Epner,et al.  Increased glyceraldehyde-3-phosphate dehydrogenase gene expression in late pathological stage human prostate cancer , 1997, Prostate Cancer and Prostatic Diseases.

[25]  J. Richter,et al.  CPEB: a life in translation. , 2007, Trends in biochemical sciences.

[26]  R. Méndez,et al.  Differential mRNA translation and meiotic progression require Cdc2‐mediated CPEB destruction , 2002, The EMBO journal.